Kieger Sustainable Healthcare Fund Class A CHF (H) Accumulating

Reference Data

ISIN LU2492015610
Valor Number 120608809
Bloomberg Global ID
Fund Name Kieger Sustainable Healthcare Fund Class A CHF (H) Accumulating
Fund Provider Kieger AG Kieger AG
Limmatstrasse 264, CH-8005 Zürich
Phone: +41 44 444 18 44
Web: https://kieger.com/
E-Mail: info@kieger.com
Fund Provider Kieger AG
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager.
Peculiarities

Fund Prices

Current Price * 99.21 CHF 17.11.2025
Previous Price * 99.65 CHF 14.11.2025
52 Week High * 104.77 CHF 05.02.2025
52 Week Low * 89.41 CHF 07.08.2025
NAV * 99.21 CHF 17.11.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 179,072,235
Unit/Share Assets *** 1,039,984
Trading Information SIX

Performance

YTD Performance +2.41% 31.12.2024
17.11.2025
1 month +2.78% 17.10.2025
17.11.2025
3 months +5.61% 18.08.2025
17.11.2025
6 months +3.68% 19.05.2025
17.11.2025
1 year -1.40% 18.11.2024
17.11.2025
2 years +5.53% 17.11.2023
17.11.2025
3 years +3.15% 17.11.2022
17.11.2025
5 years -0.79% 04.08.2022
17.11.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 6.00%
AstraZeneca PLC 5.92%
Abbott Laboratories 5.59%
Novartis AG Registered Shares 5.45%
Roche Holding AG 5.29%
UnitedHealth Group Inc 4.40%
Boston Scientific Corp 4.27%
Novo Nordisk AS Class B 3.61%
Danaher Corp 3.51%
Stryker Corp 3.30%
Last data update 31.08.2025

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee *** 0.85%
Ongoing Charges *** 1.34%
SRRI ***
SRRI date *** 30.04.2024

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)